logo

For the Inventor, By the Inventor

Princeton, NJ, United States of America

Jacobus Pharmaceutical Company, Inc.

Calculating rank
USPTO Granted Patents = 11

% Expired Patents = 36.4



Trademarks = 2

Forward Citations = 21

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal David Penman Jacobus (8 out of 16 patents)

silverMedal Guy A Schiehser (5 out of 40 patents)

bronzeMedal Hong-Ming Shieh (4 out of 5 patents)

4.  Norman P Jensen (4 out of 13 patents)

5.  Wenyi Zhao (3 out of 5 patents)

6.  Jacek Terpinski (3 out of 3 patents)

7.  Gavin David Heffernan (2 out of 20 patents)

8.  Neil J Lewis (2 out of 2 patents)

9.  Rajendra Shah (1 out of 2 patents)

10.  Kurt William Saionz (1 out of 19 patents)

11.  Dana J Giulian (1 out of 8 patents)

12.  Craig Canfield (1 out of 1 patent)

13.  Robert Bliss (1 out of 1 patent)

14.  Vithal Patel (1 out of 1 patent)

15.  David P Jacobus (0 patent)


11 patents:

1. 10626088 - Determining degradation of 3,4-diaminopyridine (2020-04-21),
2. 9409893 - Heteroaryl derivatives and uses thereof (2016-08-09),
3. 8962657 - Aryl derivatives and uses thereof (2015-02-24),
4. 8334100 - Methods for diagnosis and monitoring of neurological disease by detection of an excephalotoxin (2012-12-18),
5. 7563792 - Biguanide and dihydrotriazine derivatives (2009-07-21),
6. 7256218 - Biguanide and dihydrotriazine derivatives (2007-08-14),
7. 6693217 - Antimalarial N,N′-substituted biguanides derived from hydroxylamines (2004-02-17),
8. 6551614 - Antimalarial N,N′-substituted biguanides derived from hydroxylamines (2003-04-22),
9. 5834492 - Water soluble orally effective iron chelator (1998-11-10),
10. 5658952 - 1-[4-(4'-sulfanilyl)phenyl]urea and derivatives for the treatment of (1997-08-19),
11. 5322858 - N,N'-substituted imidodicarbonimidic diamides derived from hydroxylamines (1994-06-21),
Company Overview
Jacobus Pharmaceutical Company, Inc. is a biopharmaceutical firm based in Princeton, NJ, specializing in the development and commercialization of innovative therapies for rare diseases. The company focuses on addressing unmet medical needs through advanced research and development in the pharmaceutical sector. With a commitment to improving patient outcomes, Jacobus leverages its expertise in drug formulation and delivery, aiming to provide effective solutions for patients with complex health challenges.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

11 Patents

#74 in Princeton, NJ

#1,029 in New Jersey

#27,540 in US

#51,831 in the World

Princeton, NJ (US)
Princeton, NJ, United States of America

Jacobus Pharmaceutical Company, Inc.

Forward Citations = 21

14 inventors:

goldMedal David Penman Jacobus (8 out of 16 patents)

silverMedal Guy A Schiehser (5 out of 40 patents)

bronzeMedal Hong-Ming Shieh (4 out of 5 patents)

4.  Norman P Jensen (4 out of 13 patents)

5.  Wenyi Zhao (3 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Jacobus Pharmaceutical Company, Inc.. Retrieved from https://idiyas.com/company/jacobus-pharmaceutical-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…